Therapeutic Advances in Drug Safety

Aims & Scope

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients.

The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem

  Citation: 1430

  Authors: Carl, Lars

• Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review

  Citation: 489

  Authors: Konstantinos E., Riccardo

• Predicting risk of adverse drug reactions in older adults

  Citation: 338

  Authors: Amanda Hanora, Paul

• An overview of prevalence, determinants and health outcomes of polypharmacy

  Citation: 299

  Authors: Mina, Chris J., Alison D., Phyo K.

• Naloxone dosage for opioid reversal: current evidence and clinical implications

  Citation: 280

  Authors: Rachael, JL

• Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource

  Citation: 250

  Authors: Tim, Tjeerd, Shivani, Susan

• Drug-induced QT interval prolongation: mechanisms and clinical management

  Citation: 244

  Authors: Senthil, Manish D., Jeffrey M.

• Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence

  Citation: 182

  Authors: Marina L., Danielle R., Sunny Anne

• Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future

  Citation: 181

  Authors: Muaed, Ali M, Nageeb, Subish

• Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies

  Citation: 177

  Authors: Marlies R., Maarten, Klaas A.